Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Jac-Antimicrobial Resistance
|
February 2, 2023
Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
Mical Paul, Yael Dishon-Benattar, Yaakov Dickstein, et al.
The Journal of Antimicrobial Chemotherapy
|
September 15, 2016
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
Oren Zusman, Sergey Altunin, Fidi Koppel, et al.
The Journal of Antimicrobial Chemotherapy
|
January 28, 2025
Ceftaroline versus vancomycin for methicillin-resistant Staphylococcus aureus bacteraemia, a matched cohort study
Roni Bitterman, Aya Awwad, Basel Darawsha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 30, 2016
The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
Yael Dishon Benattar, Muna Omar, Oren Zusman, et al.
Eclinicalmedicine
|
December 9, 2022
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis
Adi Turjeman, Elodie von Dach, José Molina, et al.
Clinical and Translational Science
|
July 2, 2024
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes
Vincent Aranzana-Climent, Wisse van Os, Amir Nutman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 3, 2018
The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study
Yael Zak-Doron, Yael Dishon Benattar, Iris Pfeffer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
Amir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Virulence
|
August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> clades
Mor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms
Yaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Jac-Antimicrobial Resistance
|
February 2, 2023
Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
Mical Paul, Yael Dishon-Benattar, Yaakov Dickstein, et al.
The Journal of Antimicrobial Chemotherapy
|
September 15, 2016
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
Oren Zusman, Sergey Altunin, Fidi Koppel, et al.
The Journal of Antimicrobial Chemotherapy
|
January 28, 2025
Ceftaroline versus vancomycin for methicillin-resistant Staphylococcus aureus bacteraemia, a matched cohort study
Roni Bitterman, Aya Awwad, Basel Darawsha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 30, 2016
The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
Yael Dishon Benattar, Muna Omar, Oren Zusman, et al.
Eclinicalmedicine
|
December 9, 2022
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis
Adi Turjeman, Elodie von Dach, José Molina, et al.
Clinical and Translational Science
|
July 2, 2024
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes
Vincent Aranzana-Climent, Wisse van Os, Amir Nutman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 3, 2018
The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study
Yael Zak-Doron, Yael Dishon Benattar, Iris Pfeffer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
Amir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Virulence
|
August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> clades
Mor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms
Yaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
Page
of 2